logo
Plus   Neg
Share
Email

EPR Properties Increases 2018 Earnings Guidance - Quick Facts

EPR Properties (EPR) increased its 2018 guidance for FFO as adjusted per diluted share to a range of $5.97 to $6.07 from a range of $5.75 to $5.90. The company narrowed its 2018 investment spending guidance to a range of $450.0 million to $650.0 million from a range of $400.0 million to $700.0 million and increased 2018 disposition proceeds guidance to a range of $450.0 million to $500.0 million from a range of $350.0 million to $450.0 million.

FFO as adjusted for the second quarter of 2018 was $141.8 million, or $1.87 per diluted common share, compared to $94.9 million, or $1.29 per diluted common share, for the same quarter in 2017, representing a 45% increase in per share results. Total revenue was $202.9 million for the second quarter of 2018, including a $45.9 million prepayment fee received from Och-Ziff Real Estate, and represents a 37% increase from $147.8 million for the same quarter in 2017.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT